keratins - OmicsDI

Show results for

Proteomics (651)
Unknown (462)
Transcriptomics (88)
Genomics (70)
Methylation profiling (1)
Other (1)
Multiomics (1)
Metabolomics (1)

Organisms

Allexis (614)
Arabidopsis thaliana (614)
Homo sapiens (614)
Listeria monocytogenes (614)
Mus musculus (614)
Rattus norvegicus (614)
Saccharomyces cerevisiae (614)
Schizosaccharomyces pombe (614)
Shigella (614)
Shigella flexneri (614)
Callinectes sapidus (613)
Cyanophora paradoxa (613)
Ensifer adhaerens (613)
Entamoeba histolytica (613)
Escherichia coli (613)
Histomonas meleagridis (613)
Leishmania major strain Friedlin (613)
Medicago truncatula (613)
Methylohalobius crimeensis 10Ki (613)
Mycobacterium tuberculosis (613)
Oryza sativa Indica Group (613)
Homo sapiens (59)
Mus musculus (31)
Rattus norvegicus (4)
Gallus gallus (2)
Rana pirica (1)
Acipenser medirostris (1)
Acipenser transmontanus (1)
Bos taurus (1)
Danio rerio (1)

Organisms

Homo sapiens (34)
Mus musculus (13)
Rattus norvegicus (2)
Gallus gallus (2)
Hemiphyllodactylus yunnanensis (1)
Takifugu rubripes (1)
Danio rerio (1)
Bos taurus (1)

Repository

pride (614)
ENA (62)
geo (55)
biostudies-arrayexpress (39)
MassIVE (35)
EGA (4)
iProX (2)
MetaboLights (1)

Tissue

Cell culture (118)
Brain (30)
Epithelial cell (27)
Permanent cell line cell (27)
Skin (18)
Blood plasma (17)
Plant cell (16)
Liver (14)
Cell suspension culture (13)
Skeletal muscle (12)
Leaf (11)
Blood (10)
Embryo (10)
Fibroblast (10)
Embryonic stem cell (9)
Heart (9)
Macrophage (9)
Blood cell (7)
Bone (7)
Brown adipose tissue (7)
Hepatocyte (7)
Lung (7)
Root (7)
Saliva (7)
Blood serum (6)
Kidney (6)
Seedling (6)
Whole body (6)
Bone marrow (5)
Cell line cell (5)

Disease

Disease free (15)
Breast cancer (8)
Alzheimer's disease (6)
Colon cancer (5)
Trypanosomiasis (5)
Type 2 diabetes mellitus (5)
Cervix carcinoma (4)
Acute leukemia (3)
Brain cancer (3)
Glioblastoma (3)
Influenza (3)
Malignant neoplasm of ovary (3)
Pancreatic ductal adenocarcinoma (3)
Parkinson's disease (3)
Amyotrophic lateral sclerosis (2)
Cardiovascular system disease (2)
Crohn's disease (2)
Epidermolysis bullosa simplex (2)
Obesity (2)
Oral squamous cell carcinoma (2)
Paranoid schizophrenia (2)
Pulmonary hypertension (2)
Recessive dystrophic epidermolysis bullosa (2)
Respiratory syncytial virus infectious disease (2)
Skin melanoma (2)
Temporal lobe epilepsy (2)
Wounds and Injuries (2)
Keratoconus (1)
Burkitt lymphoma (1)
COVID-19 (1)

Technology Type

Mass Spectrometry (614)
Shotgun proteomics (316)
Bottom-up proteomics (125)
Affinity purification coupled with mass spectrometry proteomics (99)
Data-dependent acquisition (71)
Gel-based experiment (67)
Data-independent acquisition (29)
Top-down proteomics (14)
Chemical cross-linking coupled with mass spectrometry proteomics (4)
SWATH MS (4)
Affinity proteomics (3)
SRM/MRM (3)
HDMSE (2)
ION_TORRENT, Ion Torrent Proton (1)
Illumina HiSeq 4000, ILLUMINA (1)
Mass spectrometry (1)
All-ion fragmentation (1)
DiaPASEF (1)
MSE (1)
Mass spectrometry imaging (1)

Instrument Platform

LTQ (13)
LTQ Orbitrap (8)
LTQ Orbitrap Velos (6)
LTQ Orbitrap Elite (4)
LTQ XL (3)
Q Exactive (2)
Q Exactive Plus (2)
Nanostring GeoMx spatial profiler (1)
Illumina NovaSeq 6000 (1)
NextSeq 500 (1)
Orbitrap Exploris 480 (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2025 (90)
2024 (87)
2022 (81)
2026 (78)
2023 (73)
2021 (62)
2020 (47)
2016 (41)
2018 (37)
2019 (34)
2015 (33)
2013 (22)
2017 (22)
2014 (14)
2011 (7)
2012 (4)
2008 (3)
2009 (2)
2007 (2)
2005 (2)
2006 (2)
2010 (1)

Metabolite Name

5-n-acetyl-7-n-(d-alanyl)-legionaminic acid (1)
Glandicoline a (1)
Roquefortine d (1)
Histidyltryptophyldiketopiperazine (1)
Gamma-l-glutamyl-l-propargylglycine (1)
4alpha-carboxy-stigmasta-7,24(24(1))-dien-3beta-ol (1)
N8,n'8-citryl-bis(spermidine) (1)
Cyclooctatin (1)
9-hydroxy-12-oxo-15(z)-octadecenoic acid (1)
Ent-3beta-hydroxycassa-12,15-dien-2-one (1)
Salviol (1)
Biliverdin-ix-beta (1)
(3r)-3-hydroxy-16-methoxy-1,2-didehydro-2,3-dihydrotabersonine (1)
Roseoflavin (1)
Narcotoline hemiacetal (1)
(13s,14r)-1-hydroxy-13-o-acetyl-n-methylcanadine (1)
(13s,14r)-1,13-dihydroxy-n-methylcanadine (1)
(s)-1-hydroxy-n-methylcanadine (1)
Oryzalexin e (1)
Ent-sandaracopimaradien-3beta-ol (1)
(1r,10as)-1,4,10,10a-tetrahydrophenazine-1,6-dicarboxylate (1)
5-methylphenazine-1-carboxylate (1)
Nebramine (1)
4'-oxonebramine (1)
2-aminovalienone (1)
Validamine 7-phosphate (1)
Gamma-l-glutamyl-s-(hercyn-2-yl)-l-cysteine s-oxide (1)
S-(hercyn-2-yl)-l-cysteine s-oxide (1)
Glucoselysine (1)
L-anticapsin (1)

First Public Date

2014 (16)
2026 (10)
2025 (9)
2023 (5)
2015 (5)
2024 (3)
2020 (3)
2017 (3)
2016 (3)
2021 (2)
2018 (2)
2022 (1)

Modification

4-tetrahydrothiazine-3-carboxylic acid (5)
57.021464 (5)
15.994915 (4)
42.010565 (2)
-17.026549 (1)
0.984016 (1)
14.01565 (1)
19.989829 (1)
1x(15)N labeled L-leucine (1)
28.0313 (1)
3.994915 (1)
4-dinitrophenyl modified residue (1)
79.966331 (1)
N6-dimethyl-L-lysine (1)
Not available (1)

Study type

Transcription profiling by array (27)
RNA-seq of coding RNA (4)
Transcription profiling by SAGE (3)
Spatial transcriptomics by high-throughput sequencing (2)
Methylation profiling by array (2)
ChIP-seq (1)

Release Date

2020 (40)
2025 (38)
2021 (36)
2022 (34)
2024 (33)
2019 (32)
2013 (31)
2016 (30)
2014 (30)
2023 (30)
2015 (26)
2018 (25)
2017 (23)
2012 (13)
2007 (13)
2011 (10)
2009 (9)
2026 (9)
2010 (9)
2008 (7)
2005 (6)
2006 (6)
2004 (3)
2001 (3)
2003 (2)
2002 (2)
1998 (1)

Lab affiliation

EDyP (45)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (24)
Department of Biology, University of Fribourg Chemin du Musée 10, 1700 Fribourg, Switzerland T +41 26 300 8631 (13)
Laboratoire de Spectrométrie de Masse BioOrganique, Analytical Science department, IPHC, CNRS, Strasbourg University, UMR7178, Strasbourg, France (9)
Harvard Medical School (5)
Institute of Physiology II Universität Freiburg Germany (5)
Department of Cell Biology, Harvard Medical School, Boston, MA, USA (4)
Department of Medicine, Columbia University Irving Medical Center (4)
Stowers Institute for Medical Research (4)
Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland (3)
Chemical and Biological Engineering, The Hong Kong University of Science and Technology (HKUST) (3)
Dana-Farber Cancer Institute and Harvard Medical School (3)
Faculty of Chemistry, Biotechnology and Food Science. Norwegian University of Life Sciences. (3)
Globe Institute, University of Copenhagen, Denmark (3)
MRC Toxicology Unit, University of Cambridge (3)
Biozentrum, University of Basel, 4056 Basel, Switzerland (2)
Chemical and Biological Engineering Department, The Hong Kong University of Science and Technology (HKUST) (2)
Chemical and Biological Engineering, Hong Kong University of Science and Technology (HKUST) (2)
Dep. of Biology, University of Fribourg, Chemin du Musee 10, CH-1700 Fribourg (2)
Department of Biology University of California, Riverside (2)
Department of Biology, University of Fribourg Chemin du Musée 10, 1700 Fribourg, Switzerland (2)
Department of Biology, University of Fribourg Chemin du Musée 10, 1700 Fribourg, Switzerland T +41 26 300 8631 E joern.dengjel@unifr.ch (2)
Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland (2)
Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology (HKUST) (2)
Department of Fundamental Neurosciences, Rue du Bugnon 9, 1005, Lausanne (2)
Department of Genome Sciences, University of Washington, Seattle, WA 98195 USA (2)
Department of Immunobiology, University of Lausanne (155 chemin des Boveresses 1066 Epalinges Switzerland) (2)
Department of Inflammation and Immunity, Gastroenterology and Hepatology. Cleveland Clinic, Cleveland Ohio (2)
Department of Life and Environmental Sciences, University of Cagliari (2)
Department of Medical Biotechnology and Laboratory Science College of Medicine, Chang Gung University, Taoyuan, Taiwan (2)

Previous page
1 / 128
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 128
Next page

Sort by:

Relevance

Page size

Mass spectrometric detection of keratins in tear fluid

Keratin contamination is a common problem in mass spectrometry proteomic analyses, particularly in bottom-up mass spectrometry. The purpose of this study was to determine the protein contaminants introduced during the proteomic analysis of tear fluid.Human tear fluid samples were collected using Sch...

ORGANISM(S): Homo sapiens (Human)

2025-03-03 | PXD061409 | Pride

Cytoskeletal Keratins Are Overexpressed in a Zebrafish Model 2 of Idiopathic Scoliosis

PRJNA966993 | ENA

Mass spectrometric detection of keratins in tear fluid.

Not available

S-EPMC11798696 | biostudies-literature

Keratins mediate localization of hemidesmosomes and repress cell motility.

Not available

S-EPMC3575009 | biostudies-literature

Keratins control intercellular adhesion involving PKC-α-mediated desmoplakin phosphorylation.

Not available

S-EPMC3664716 | biostudies-literature

Diseases of epidermal keratins and their linker proteins.

Not available

S-EPMC2578874 | biostudies-literature

Keratins Regulate p38MAPK-Dependent Desmoglein Binding Properties in Pemphigus.

Not available

S-EPMC5868517 | biostudies-literature

Keratins significantly contribute to cell stiffness and impact invasive behavior.

Not available

S-EPMC3832002 | biostudies-literature

Unique amino acid signatures that are evolutionarily conserved distinguish simple-type, epidermal and hair keratins.

Not available

S-EPMC3258107 | biostudies-literature

Keratins control Nrf2 by regulating mitochondrial activity and barrier composition / Keratin-dependent TSLP expression suggests a link between skin blistering and atopic disease

The epidermal barrier protects the body against mechanical injury, infection and dehydration. The respective contribution of type I and type II keratins which form the major cytoskeleton in epidermal keratinocytes in barrier formation and stress protection is incompletely understood. Here, we reveal...

ORGANISM(S): Mus musculus

2016-03-26 | GSE79590 | GEO

Previous page
1 / 128
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 128
Next page

Sort by:

Relevance

Page size

1274 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets